Stemline raises $33.2 million in IPO

Stemline Therapeutics Inc. (NASDAQ:STML) was up $1.80 (18%) to $11.80 in its first day of trading on Tuesday after the company raised $33.2 million through the sale of 3.3 million shares at $10 in an IPO. Aegis Capital; Feltl; and Sunrise Securities were underwriters. The price values Stemline at $69.6 million. Earlier this month, Stemline amended its IPO and said it planned to sell 2.3 million shares at $10-$12. An $11 price would have raised $25 million and valued the company at $65 million. ...